Geode Capital Management, LLC Aspira Women'S Health Inc. Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.3 - $0.41 $412 - $564	-1,376 Reduced 0.23%	597,758 $198,000
Q2 2022 Aug 12, 2022	SELL	$0.4 - $1.09 $217,890 - $593,750	-544,725 Reduced 47.62%	599,134 $351,000
Q1 2022 May 13, 2022	SELL	$0.88 - $1.81 $18,988 - $39,056	-21,578 Reduced 1.85%	1,143,859 $1.19 Million
Q4 2021 Feb 11, 2022	SELL	$1.63 - $3.43 $32,184 - $67,725	-19,745 Reduced 1.67%	1,165,437 $2.06 Million
Q3 2021 Nov 12, 2021	BUY	$3.19 - $5.48 $68,023 - $116,855	21,324 Added 1.83%	1,185,182 $3.85 Million

Q2 2021 Aug 13, 2021	SELL	$4.78 - $6.84 $286,451 - $409,900	-59,927 Reduced 4.9%	1,163,858 $6.54 Million
Q1 2021 May 12, 2021	BUY	$5.9 - $9.13 $1.11 Million - $1.72 Million	188,764 Added 18.24%	1,223,785 $8.26 Million
Q4 2020 Feb 12, 2021	BUY	$3.0 - $6.71 $197,205 - $441,081	65,735 Added 6.78%	1,035,021 $6.94 Million
Q3 2020 Nov 13, 2020	BUY	$2.54 - $4.56 $557,999 - $1 Million	219,685 Added 29.31%	969,286 $2.99 Million
Q2 2020 Aug 13, 2020	BUY	$0.78 - $5.25 $584,688 - $3.94 Million	749,601 New	749,601 $2.88 Million

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $185M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.